This inventor holds 1 USPTO granted patent, plus 3 CIPO patents. Top assignee: University of Toronto. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Methvin Isaac: Innovator in Kinase Inhibition
Introduction
Methvin Isaac is a notable inventor based in Brampton, Canada. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific kinases involved in various diseases.
Latest Patents
Methvin Isaac holds a patent for "Isoindolinone aminopyrimidine compounds as inhibitors of NUAK kinases, compositions and uses thereof." This patent relates to compounds of Formula (I) or pharmaceutically acceptable salts, solvates, and/or prodrugs thereof. The invention focuses on compositions comprising these compounds and their various uses in treating diseases, disorders, or conditions that can be addressed by inhibiting or blocking NUAK kinase, such as cancers and fibrosis. He has 1 patent to his name.
Career Highlights
Methvin Isaac is affiliated with the University of Toronto, where he continues to engage in research and development in the field of kinase inhibitors. His work is pivotal in advancing therapeutic options for patients suffering from serious health conditions.
Collaborations
He collaborates with esteemed colleagues, including Rima Al-Awar and David Uehling, to further enhance the impact of his research and innovations.
Conclusion
Methvin Isaac's contributions to the field of medicinal chemistry and his innovative patent on kinase inhibitors highlight his role as a significant figure in the fight against diseases like cancer and fibrosis. His work continues to inspire advancements in therapeutic research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile